[Retracted] Comparison of Clinical Effects of Temozolomide Single Agent and Combined Doxorubicin in the Treatment of Glioma

Table 1

The general information.

General information		Observation group	Control group
Cases		35	35	＞0.05
Age (average)		50.61 ± 4.69	51.67 ± 3.51	＞0.05
Gender	Boy	19	20	＞0.05
	Girl	16	15
Tumor grade	III	22	21	＞0.05
	IV	13	14
Tumor location	Temporal lobe	10	11	＞0.05
	Frontal lobe	9	10
	Parietal lobe	6	5
	Occipital	6	7
	Others	4	2